Verburg, Frederik A. http://orcid.org/0000-0002-7161-0979
Flux, Glenn
Giovanella, Luca
van Nostrand, Douglas
Muylle, Kristoff
Luster, Markus
Article History
Received: 28 June 2019
Accepted: 6 August 2019
First Online: 15 October 2019
Compliance with ethical standards
:
: FAV is a consultant to SanofiGenzyme, Jubilant Draximage, and EISAI, has received research support from EISAI, and has received speaker honoraria from Diasorin. LG is a consultant to Roche Diagnostics and SanofiGenzyme, has received research support from Roche Diagnostics, and has received speaker honoraria from Roche Diagnostics and SanofiGenzyme. DVN is a consultant to and has received speaker honoraria from Jubilant Draximage. ML was a consultant for AstraZeneca, Bayer Healthcare, SanofiGenzyme, EASAI, Jubilant Draximage, and Sobi and has received speaker honoraria and research support from SanofiGenzyme, Henning, and Merck.GF and KM have no conflict of interest to declare.
: Not applicable.
: Not applicable.
: The work described in this paper was financially supported by the European Association of Nuclear Medicine.The analysis performed for this paper was performed by the firm “Ärztliches Zentrum für Qualitätsmanagement”, Berlin, Germany, in a commercial commission by the European Association of Nuclear Medicine.